December 21, 2017
Last Patient Last Visit (LPLV) completed in Phase II Study for the Treatment of Calcific Uraemic Arteriolopathy in End Stage Renal Disease Patients Palma, Spain and San Diego, USA, December 21, 2017 – Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, announced today that the Last Patient’s Last Visit (LPLV) occurred...


Eske Willerslev receives prestigious Norwegian science prize for his Lundbeck Foundation research on brain disorders
22. January 2021
Science Programme Director (Open Neuroplatform)
18. January 2021
Scientific Programme Director (Talent programs)
15. January 2021


Lundbeckfonden Ventures

Lundbeckfonden Emerge